Research ArticleDRUG THERAPY
Targeting NF-κB in glioblastoma: A therapeutic approach
- Dinorah Friedmann-Morvinski1,2,*,
- Rajesh Narasimamurthy1,†,
- Yifeng Xia1,
- Chad Myskiw1,
- Yasushi Soda1 and
- Inder M. Verma1,*
- 1Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
- 2Department of Biochemistry and Molecular Biology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel.
- ↵*Corresponding author. E-mail: verma{at}salk.edu (I.M.V.); dino{at}post.tau.ac.il (D.F.-M.)
↵† Present address: Thermo Fisher Scientific, Whitefield, Bangalore 560066, India.
See allHide authors and affiliations
Science Advances 08 Jan 2016:
Vol. 2, no. 1, e1501292
DOI: 10.1126/sciadv.1501292
Vol. 2, no. 1, e1501292
DOI: 10.1126/sciadv.1501292
Dinorah Friedmann-Morvinski
Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.Department of Biochemistry and Molecular Biology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel.
Rajesh Narasimamurthy
Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
Yifeng Xia
Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
Chad Myskiw
Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
Yasushi Soda
Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
Inder M. Verma
Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
